<scp>FGF7</scp> / <scp>FGFR2</scp> – <scp>JunB</scp> signalling counteracts the effect of progesterone in luminal breast cancer-Reference-Cited by-同舟云学术

FGF7 / FGFR2 – JunB signalling counteracts the effect of progesterone in luminal breast cancer

Published:2022-07-04 Issue:15 Volume:16 Page:2823-2842
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Mieczkowski Kamil¹,Kitowska Kamila¹,Braun Marcin²^ORCID,Galikowska‐Bogut Barbara¹^ORCID,Gorska‐Arcisz Monika¹,Piasecka Dominika¹,Stawiski Konrad³,Zaczek Anna J.⁴,Nejc Dariusz⁵,Kordek Radzisław²,Romanska Hanna M.²,Sadej Rafal¹^ORCID

Affiliation:

1. Department of Molecular Enzymology and Oncology, Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk Poland

2. Department of Pathology, Chair of Oncology Medical University of Lodz Poland

3. Department of Biostatistics and Translational Medicine Medical University of Lodz Poland

4. Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology Medical University of Gdansk Poland

5. Department of Surgical Oncology Medical University of Lodz Poland

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13274

Reference63 articles.

1. Breast cancer intrinsic subtype classification, clinical use and future trends;Dai X;Am J Cancer Res,2015